Rover's rapid COVID-19 test advances to phase I of RADx

By LabPulse.com staff writers

October 2, 2020 -- The U.S. National Institutes of Health (NIH) has selected a COVID-19 rapid test from Rover Diagnostics and Columbia Engineering for phase I of the Rapid Acceleration of Diagnostics (RADx) initiative.

The affordable, portable, and fast point-of-care Rover test provides reverse transcription polymerase chain reaction (RT-PCR) results in eight minutes with accuracy that matches laboratory-based tests. The RCR, weighing 2 lb, can be used by anyone due to sample preparation techniques developed at the lab of Columbia biomedical engineering professor Sam Sia, PhD. The approach combines thermal cycling and uses a photothermal process that relies on nanoparticles to generate heat from inside.

Rover
Close-up of early Rover photothermal PCR prototype, a new COVID-19 rapid-testing technology platform developed by Rover Diagnostics and Columbia Engineering. Image courtesy of Rover Diagnostics.

The Rover platform can also test for a broad range of infectious diseases including flu, strep, and other viruses that require fast diagnosis. Its sensitivity is higher than with other types of tests such as isothermal, antigen, and CRISPR, according to Rover.

The Rover team is among 33 companies to advance to RADx's phase I level.

United Airlines launches pilot COVID-19 testing program
United Airlines has announced a pilot COVID-19 testing program for travelers in which customers traveling on United from San Francisco International Airport...
Rapid point-of-care COVID-19 test shows promise in clinical study
A rapid COVID-19 test that can produce results at the point of care in just 90 minutes without sending samples to a central lab has demonstrated 94% sensitivity...
Experts draw lessons from FDA's hydroxychloroquine EUA controversy
Public health and regulatory experts advocated for changes to the U.S. Food and Drug Administration (FDA) emergency use authorization (EUA) process in...
Point-of-care testing leads South Korea's response to COVID-19
What was the secret to South Korea's success in controlling the COVID-19 pandemic? A new study indicates that point-of-care testing played an important...
Lab-on-a-chip array could provide low-cost SARS-CoV-2 antibody test
The University of California, Irvine has developed a low-cost lab-on-a-chip test called TinyArray that may be available for rapid COVID-19 diagnostic...

Copyright © 2020 LabPulse.com

Last Updated np 10/6/2020 4:26:19 PM



Register below for our weekly Letter from the Editor to receive the latest Clinical Lab news and insights.
Email